Article Text

PDF
Original article
Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma
  1. DunFa Peng1,2,
  2. TianLing Hu1,2,
  3. Mohammed Soutto1,2,
  4. Abbes Belkhiri2,
  5. Alexander Zaika2,
  6. Wael El-Rifai1,2
  1. 1Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA
  2. 2Department of Surgery, Vanderbilt University Medical Center, NashvilleTennessee, USA
  1. Correspondence to Professor Wael El-Rifai, Department of Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 760 Preston Research Building, 2220 Pierce Avenue, Nashville, TN 37232, USA; wael.el-rifai{at}vanderbilt.edu.

Abstract

Objective To investigate the potential tumour suppressor functions of glutathione peroxidase 7 (GPX7) and examine the interplay between epigenetic and genetic events in regulating its expression in oesophageal adenocarcinomas (OAC).

Design In vitro and in vivo cell models were developed to investigate the biological and molecular functions of GPX7 in OAC.

Results Reconstitution of GPX7 in OAC cell lines, OE33 and FLO-1, significantly suppressed growth as shown by the growth curve, colony formation and EdU proliferation assays. Meanwhile, GPX7-expressing cells displayed significant impairment in G1/S progression and an increase in cell senescence. Concordant with the above functions, Western blot analysis displayed higher levels of p73, p27, p21 and p16 with a decrease in phosphorylated retinoblastoma protein (RB), indicating its increased tumour suppressor activities. On the contrary, knockdown of GPX7 in HET1A cells (an immortalised normal oesophageal cell line) rendered the cells growth advantage as indicated with a higher EdU rate, lower levels of p73, p27, p21 and p16 and an increase in phosphorylated RB. We confirmed the tumour suppressor function in vivo using GPX7-expressing OE33 cells in a mouse xenograft model. Pyrosequencing of the GPX7 promoter region (−162 to +138) demonstrated location-specific hypermethylation between +13 and +64 in OAC (69%, 54/78). This was significantly associated with the downregulation of GPX7 (p<0.01). Neither mutations in the coding exons of GPX7 nor DNA copy number losses were frequently present in the OAC examined (<5%).

Conclusions Our data suggest that GPX7 possesses tumour suppressor functions in OAC and is silenced by location-specific promoter DNA methylation.

  • CANCER
  • CELL CYCLE
  • GASTROINTESTINAL CANCER
  • OESOPHAGEAL CANCER

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles